STROKE DIAGNOSTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Stroke Diagnostics Market, By Stroke Type (Ischemic Stroke, Hemorrhagic Stroke, and Transient Ischemic Attack), By Imaging Test Type (Computerized Tomography (CT) Scan, Magnetic Resonance Imaging (MRI), Carotid Ultrasound, Echocardiogram, Positron Emission Tomography (PET), and Others, By End User (Diagnostic Laboratories, Hospitals, Specialty Clinics, Academic & Research Institutes, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Published In : Mar 2024
Code : CMI6794
Pages :167
Formats :
Excel and PDF
Industry : Medical Devices

Market Concentration and Competitive Landscape

Stroke Diagnostics Market Concentration By Players

Close-monitor your Competitor's Move, Request sample copy

Rising prevalence of risk factors

Rising prevalence of risk factors such as high blood pressure, obesity, diabetes, heart disease, and unhealthy lifestyle habits are significantly propelling the growth of the global stroke diagnostics market. These risk factors are becoming increasingly common around the world due to changing dietary patterns, lack of physical activity, increased stress levels and growing geriatric population. Moreover, the COVID-19 pandemic has further amplified these risk trends. Studies show that people with stroke history or risk factors like diabetes have higher chances of developing severe COVID-19. They also tend to have poorer outcomes. Prolonged stress of the pandemic along with limited mobility and access to healthcare has worsened disease management for many patients worldwide. This has boosted the demand for effective stroke screening and diagnosis solutions.

Key Players Insights